Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis -PppA induces effective protection against pneumoccocal infection in young mice
- Autores
- Vintiñi, Elisa Ofelia; Villena, Julio Cesar; Alvarez, Gladis Susana; Medina, Marcela Susana
- Año de publicación
- 2010
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Streptococcus pneumoniae is a serious public health problem, especially in developing countries, where available vaccines are not part of the vaccination calendar. We evaluated different respiratory mucosa immunization protocols that included the nasal administration of Lactococcus lactis-pneumococcal protective protein A (PppA) live, inactivated, and in association with a probiotic (Lc) to young mice. The animals that received Lc by the oral and nasal route presented the highest levels of immunoglobulin (Ig)A and IgG antiPppA antibodies in bronchoalveolar lavages (BAL) and IgG in serum, which no doubt contributed to the protection against infection. However, only the groups that received the live and inactivated vaccine associated with the oral administration of the probiotic were able to prevent lung colonization by S. pneumoniae serotypes 3 and 14 in a respiratory infection model. This would be related to a preferential stimulation of the T helper type 1 (Th1) cells at local and systemic levels and with a moderate Th2 and Th17 response, shown by the cytokine profile induced in BAL and by the results of the IgG1/IgG2a ratio at local and systemic levels. Nasal immunization with the inactivated recombinant strain associated with oral Lc administration was able to stimulate the specific cellular and humoral immune response and afford protection against the challenge with the two S. pneumoniae serotypes. The results obtained show the probiotic-inactivated vaccine association as a valuable alternative for application to human health, especially in at-risk populations, and are the first report of a safe and effective immunization strategy using an inactivated recombinant strain.
Fil: Vintiñi, Elisa Ofelia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
Fil: Villena, Julio Cesar. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
Fil: Alvarez, Gladis Susana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina
Fil: Medina, Marcela Susana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina - Materia
-
inactivated vs live vaccine
lactococcus lactis
pneumococcal infection
probiotic - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
.jpg)
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/278110
Ver los metadatos del registro completo
| id |
CONICETDig_5e519aac368e72384dc6395a67913be8 |
|---|---|
| oai_identifier_str |
oai:ri.conicet.gov.ar:11336/278110 |
| network_acronym_str |
CONICETDig |
| repository_id_str |
3498 |
| network_name_str |
CONICET Digital (CONICET) |
| spelling |
Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis -PppA induces effective protection against pneumoccocal infection in young miceVintiñi, Elisa OfeliaVillena, Julio CesarAlvarez, Gladis SusanaMedina, Marcela Susanainactivated vs live vaccinelactococcus lactispneumococcal infectionprobiotichttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Streptococcus pneumoniae is a serious public health problem, especially in developing countries, where available vaccines are not part of the vaccination calendar. We evaluated different respiratory mucosa immunization protocols that included the nasal administration of Lactococcus lactis-pneumococcal protective protein A (PppA) live, inactivated, and in association with a probiotic (Lc) to young mice. The animals that received Lc by the oral and nasal route presented the highest levels of immunoglobulin (Ig)A and IgG antiPppA antibodies in bronchoalveolar lavages (BAL) and IgG in serum, which no doubt contributed to the protection against infection. However, only the groups that received the live and inactivated vaccine associated with the oral administration of the probiotic were able to prevent lung colonization by S. pneumoniae serotypes 3 and 14 in a respiratory infection model. This would be related to a preferential stimulation of the T helper type 1 (Th1) cells at local and systemic levels and with a moderate Th2 and Th17 response, shown by the cytokine profile induced in BAL and by the results of the IgG1/IgG2a ratio at local and systemic levels. Nasal immunization with the inactivated recombinant strain associated with oral Lc administration was able to stimulate the specific cellular and humoral immune response and afford protection against the challenge with the two S. pneumoniae serotypes. The results obtained show the probiotic-inactivated vaccine association as a valuable alternative for application to human health, especially in at-risk populations, and are the first report of a safe and effective immunization strategy using an inactivated recombinant strain.Fil: Vintiñi, Elisa Ofelia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; ArgentinaFil: Villena, Julio Cesar. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; ArgentinaFil: Alvarez, Gladis Susana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; ArgentinaFil: Medina, Marcela Susana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; ArgentinaWiley Blackwell Publishing, Inc2010-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/278110Vintiñi, Elisa Ofelia; Villena, Julio Cesar; Alvarez, Gladis Susana; Medina, Marcela Susana; Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis -PppA induces effective protection against pneumoccocal infection in young mice; Wiley Blackwell Publishing, Inc; Clinical and Experimental Immunology; 159; 3; 12-2010; 351-3620009-9104CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://academic.oup.com/cei/article-abstract/159/3/351/6438786?redirectedFrom=fulltext&login=falseinfo:eu-repo/semantics/altIdentifier/doi/10.1111/j.1365-2249.2009.04056.xinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2026-01-08T12:44:21Zoai:ri.conicet.gov.ar:11336/278110instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982026-01-08 12:44:21.948CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
| dc.title.none.fl_str_mv |
Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis -PppA induces effective protection against pneumoccocal infection in young mice |
| title |
Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis -PppA induces effective protection against pneumoccocal infection in young mice |
| spellingShingle |
Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis -PppA induces effective protection against pneumoccocal infection in young mice Vintiñi, Elisa Ofelia inactivated vs live vaccine lactococcus lactis pneumococcal infection probiotic |
| title_short |
Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis -PppA induces effective protection against pneumoccocal infection in young mice |
| title_full |
Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis -PppA induces effective protection against pneumoccocal infection in young mice |
| title_fullStr |
Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis -PppA induces effective protection against pneumoccocal infection in young mice |
| title_full_unstemmed |
Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis -PppA induces effective protection against pneumoccocal infection in young mice |
| title_sort |
Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis -PppA induces effective protection against pneumoccocal infection in young mice |
| dc.creator.none.fl_str_mv |
Vintiñi, Elisa Ofelia Villena, Julio Cesar Alvarez, Gladis Susana Medina, Marcela Susana |
| author |
Vintiñi, Elisa Ofelia |
| author_facet |
Vintiñi, Elisa Ofelia Villena, Julio Cesar Alvarez, Gladis Susana Medina, Marcela Susana |
| author_role |
author |
| author2 |
Villena, Julio Cesar Alvarez, Gladis Susana Medina, Marcela Susana |
| author2_role |
author author author |
| dc.subject.none.fl_str_mv |
inactivated vs live vaccine lactococcus lactis pneumococcal infection probiotic |
| topic |
inactivated vs live vaccine lactococcus lactis pneumococcal infection probiotic |
| purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 |
| dc.description.none.fl_txt_mv |
Streptococcus pneumoniae is a serious public health problem, especially in developing countries, where available vaccines are not part of the vaccination calendar. We evaluated different respiratory mucosa immunization protocols that included the nasal administration of Lactococcus lactis-pneumococcal protective protein A (PppA) live, inactivated, and in association with a probiotic (Lc) to young mice. The animals that received Lc by the oral and nasal route presented the highest levels of immunoglobulin (Ig)A and IgG antiPppA antibodies in bronchoalveolar lavages (BAL) and IgG in serum, which no doubt contributed to the protection against infection. However, only the groups that received the live and inactivated vaccine associated with the oral administration of the probiotic were able to prevent lung colonization by S. pneumoniae serotypes 3 and 14 in a respiratory infection model. This would be related to a preferential stimulation of the T helper type 1 (Th1) cells at local and systemic levels and with a moderate Th2 and Th17 response, shown by the cytokine profile induced in BAL and by the results of the IgG1/IgG2a ratio at local and systemic levels. Nasal immunization with the inactivated recombinant strain associated with oral Lc administration was able to stimulate the specific cellular and humoral immune response and afford protection against the challenge with the two S. pneumoniae serotypes. The results obtained show the probiotic-inactivated vaccine association as a valuable alternative for application to human health, especially in at-risk populations, and are the first report of a safe and effective immunization strategy using an inactivated recombinant strain. Fil: Vintiñi, Elisa Ofelia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina Fil: Villena, Julio Cesar. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina Fil: Alvarez, Gladis Susana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina Fil: Medina, Marcela Susana. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Centro de Referencia para Lactobacilos; Argentina |
| description |
Streptococcus pneumoniae is a serious public health problem, especially in developing countries, where available vaccines are not part of the vaccination calendar. We evaluated different respiratory mucosa immunization protocols that included the nasal administration of Lactococcus lactis-pneumococcal protective protein A (PppA) live, inactivated, and in association with a probiotic (Lc) to young mice. The animals that received Lc by the oral and nasal route presented the highest levels of immunoglobulin (Ig)A and IgG antiPppA antibodies in bronchoalveolar lavages (BAL) and IgG in serum, which no doubt contributed to the protection against infection. However, only the groups that received the live and inactivated vaccine associated with the oral administration of the probiotic were able to prevent lung colonization by S. pneumoniae serotypes 3 and 14 in a respiratory infection model. This would be related to a preferential stimulation of the T helper type 1 (Th1) cells at local and systemic levels and with a moderate Th2 and Th17 response, shown by the cytokine profile induced in BAL and by the results of the IgG1/IgG2a ratio at local and systemic levels. Nasal immunization with the inactivated recombinant strain associated with oral Lc administration was able to stimulate the specific cellular and humoral immune response and afford protection against the challenge with the two S. pneumoniae serotypes. The results obtained show the probiotic-inactivated vaccine association as a valuable alternative for application to human health, especially in at-risk populations, and are the first report of a safe and effective immunization strategy using an inactivated recombinant strain. |
| publishDate |
2010 |
| dc.date.none.fl_str_mv |
2010-12 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/278110 Vintiñi, Elisa Ofelia; Villena, Julio Cesar; Alvarez, Gladis Susana; Medina, Marcela Susana; Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis -PppA induces effective protection against pneumoccocal infection in young mice; Wiley Blackwell Publishing, Inc; Clinical and Experimental Immunology; 159; 3; 12-2010; 351-362 0009-9104 CONICET Digital CONICET |
| url |
http://hdl.handle.net/11336/278110 |
| identifier_str_mv |
Vintiñi, Elisa Ofelia; Villena, Julio Cesar; Alvarez, Gladis Susana; Medina, Marcela Susana; Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis -PppA induces effective protection against pneumoccocal infection in young mice; Wiley Blackwell Publishing, Inc; Clinical and Experimental Immunology; 159; 3; 12-2010; 351-362 0009-9104 CONICET Digital CONICET |
| dc.language.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://academic.oup.com/cei/article-abstract/159/3/351/6438786?redirectedFrom=fulltext&login=false info:eu-repo/semantics/altIdentifier/doi/10.1111/j.1365-2249.2009.04056.x |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
| dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
Wiley Blackwell Publishing, Inc |
| publisher.none.fl_str_mv |
Wiley Blackwell Publishing, Inc |
| dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
| reponame_str |
CONICET Digital (CONICET) |
| collection |
CONICET Digital (CONICET) |
| instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
| _version_ |
1853774873276448768 |
| score |
13.25844 |